chr19:33790840:> Detail (hg19) (CEBPA)
Information
Genome
| Assembly | Position |
|---|---|
| hg19 | chr19:33,790,840-33,793,470 |
| hg38 | chr19:33,299,934-33,302,564 |
HGVS
| Type | Transcript | Protein |
|---|---|---|
Summary
MGeND
| Clinical significance | |
| Variant entry | |
| GWAS entry | |
| Disease area statistics | Show details |
Frequency
[No Data.]
Prediction
[No Data.]
ClinVar
| Clinical Significance | |
| Review star | [No Data.] |
| Show details | |
Links
Disease area statistics
[No Data.]
MGeND
[No Data.]
ClinVar
[No Data.]
CIViC
| Disease | Drug | EL | ET | ED | CS | VO | TR | Pubmed | Links |
|---|---|---|---|---|---|---|---|---|---|
| acute myeloid leukemia | Tretinoin | B |
|
|
Sensitivity/Response | Somatic | 3 | 19965647 | Detail |
| acute myeloid leukemia | B |
|
|
Better Outcome | Somatic | 3 | 19965647 | Detail | |
| acute myeloid leukemia | B |
|
|
Better Outcome | Somatic | 4 | 18450602 | Detail | |
| acute myeloid leukemia | B |
|
|
Better Outcome | Somatic | 3 | 14726504 | Detail | |
| acute myeloid leukemia | B |
|
|
Better Outcome | Somatic | 4 | 19304957 | Detail | |
| acute myeloid leukemia | B |
|
|
Better Outcome | Somatic | 4 | 25014773 | Detail |
DisGeNET
[No Data.]
Annotation
Annotations
| Descrption | Source | Links |
|---|---|---|
| In a randomized trial of previously untreated younger (<60) patients with acute myeloid leukemia (ex... | CIViC Evidence | Detail |
| In a group of young (<60 years old) acute myeloid leukemia (exclude acute promyelocytic leukemia) an... | CIViC Evidence | Detail |
| In young patients (age 16-60) with previously untreated, cytogenetically normal acute myeloid leukem... | CIViC Evidence | Detail |
| Overall survival and remission duration were significantly longer (p=0.01 and p=0.05, respectively) ... | CIViC Evidence | Detail |
| In children with acute myeloid leukemia, those with mutations in CEBPA had better overall and event-... | CIViC Evidence | Detail |
| In a set of 315 pediatric patients with acute myeloid leukemia, 47 had mutations in CEBPA. Those wit... | CIViC Evidence | Detail |
Overlapped Transcript Coordinates
| Gene | Transcript ID | Exon Number | Chromosome | Start | Stop | Type | Amino Mutation | Transcript Position | Links |
|---|
Overlapped Transcript
| Gene | Transcript ID | Chromosome | Start | Stop | Links |
|---|
- Gene
- -
- Genome
- hg19
- Position
- chr19:33,790,840-33,793,470
- Variant Type
- snv
- Variant (CIViC) (CIViC Variant)
- MUTATION
- Transcript 1 (CIViC Variant)
- ENST00000498907.2
- Variant URL (CIViC Variant)
- https://civic.genome.wustl.edu/links/variants/29
- Summary (CIViC Variant)
- CEBPA mutations are associated with cytogenetically normal acute myeloid leukemia (CN-AML) and a favorable prognosis. However, NPM1 and FLT3 mutations should also be assessed in CN-AML patients as concurrent mutations may have prognostic implications.
Genome browser